Table of Content

1 INTRODUCTION (Page No. - 30)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 STUDY SCOPE
          FIGURE 1 MARKET SEGMENTATION
           1.3.1 REGIONS COVERED
    1.4 YEARS CONSIDERED
    1.5 CURRENCY CONSIDERED
          TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019-2021
    1.6 UNIT CONSIDERED
    1.7 STAKEHOLDERS
    1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
          FIGURE 2 ANIMAL INTESTINAL HEALTH MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primary interviews
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
          FIGURE 4 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (1/2)
          FIGURE 5 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (2/2)
          FIGURE 6 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: DEMAND SIDE
           2.2.1 BOTTOM-UP APPROACH
                     FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
                     FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
           2.4.1 ASSUMPTIONS
           2.4.2 LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 47)
    FIGURE 10 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
    FIGURE 11 POULTRY SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
    FIGURE 12 DRY FORM SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE BY 2022
    FIGURE 13 MICROBIAL SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SIZE BY 2027
    FIGURE 14 ASIA PACIFIC EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022

4 PREMIUM INSIGHTS (Page No. - 51)
    4.1 OPPORTUNITIES IN ANIMAL INTESTINAL HEALTH MARKET
          FIGURE 15 INCREASE IN DEMAND FOR FEED AND FEED ADDITIVES DRIVING GROWTH OF ANIMAL INTESTINAL HEALTH MARKET
    4.2 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE
          FIGURE 16 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
    4.3 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK AND KEY COUNTRIES
          FIGURE 17 CHINA AND POULTRY SEGMENT EXPECTED TO ACCOUNT FOR SIGNIFICANT MARKET SHARE IN ASIA PACIFIC MARKET IN 2022
    4.4 ANIMAL INTESTINAL HEALTH MARKET, BY FORM AND REGION
          FIGURE 18 DRY SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE IN 2022
    4.5 ANIMAL INTESTINAL HEALTH MARKET, BY MAJOR REGIONAL SUBMARKETS
          FIGURE 19 CHINA EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022

5 MARKET OVERVIEW (Page No. - 54)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 20 ANIMAL INTESTINAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increased production of compound feed
                                FIGURE 21 GLOBAL COMPOUND FEED PRODUCTION, 2012–2021 (MILLION METRIC TONS)
                                FIGURE 22 COMPOUND FEED PRODUCTION, BY TOP 7 COUNTRIES, 2016–2020 (MILLION METRIC TONS)
                    5.2.1.2 Rising demand for animal protein
                                TABLE 2 PER CAPITA CONSUMPTION OF LIVESTOCK PRODUCTS, BY REGION
                    5.2.1.3 Intestinal disorders among livestock
           5.2.2 RESTRAINTS
                    5.2.2.1 Stringent regulations for use of feed additives
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Innovations and technological advancements in feed industry
                    5.2.3.2 Increased awareness about feed and food safety
           5.2.4 CHALLENGES
                    5.2.4.1 High cost of feed additives
                               5.2.4.1.1 R&D costs associated with development of probiotics
                               5.2.4.1.2 High cost of active ingredients used in development of phytogenic feed additives

6 INDUSTRY TRENDS (Page No. - 61)
    6.1 INTRODUCTION
    6.2 TRENDS IMPACTING CUSTOMERS’ BUSINESS
           FIGURE 23 TRENDS IMPACTING ANIMAL INTESTINAL HEALTH MARKET
    6.3 VALUE CHAIN
           FIGURE 24 VALUE CHAIN ANALYSIS
    6.4 TRADE ANALYSIS
           FIGURE 25 EXPORT OF LIVESTOCK SPECIES, 2016–2021 (USD MILLION)
    6.5 TECHNOLOGY ANALYSIS
    6.6 PATENT ANALYSIS
           TABLE 3 KEY PATENTS PERTAINING TO ANIMAL INTESTINAL HEALTH, 2019–2022
    6.7 ECOSYSTEM MAP
           6.7.1 ANIMAL INTESTINAL HEALTH MARKET: ECOSYSTEM MAP
                    FIGURE 26 FEED AND ANIMAL NUTRITION: ECOSYSTEM MAP
    6.8 PORTER’S FIVE FORCES ANALYSIS
          TABLE 4 PORTER’S FIVE FORCES ANALYSIS
           6.8.1 THREAT OF NEW ENTRANTS
           6.8.2 THREAT OF SUBSTITUTES
           6.8.3 BARGAINING POWER OF SUPPLIERS
           6.8.4 BARGAINING POWER OF BUYERS
           6.8.5 INTENSITY OF COMPETITIVE RIVALRY
    6.9 CASE STUDIES
           6.9.1 REGULATIONS ON ANTIBIOTICS LEADING TO A SHIFT TOWARD PROBIOTICS
    6.10 PRICING ANALYSIS
           6.10.1 ANIMAL INTESTINAL HEALTH MARKET: AVERAGE SELLING PRICE TREND ANALYSIS
                      TABLE 5 AVERAGE SELLING PRICE, BY ADDITIVE, 2019–2027 (USD/KG)
    6.11 REGULATORY FRAMEWORK
           6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           6.11.2 CODEX ALIMENTARIUS COMMISSION (CAC)
                    6.11.2.1 North America
                    6.11.2.2 Europe
                    6.11.2.3 Asia Pacific
    6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
           6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                      FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING ANIMAL INTESTINAL HEALTH PRODUCTS
                      TABLE 6 INFLUENCE OF STAKEHOLDERS ON TOP THREE PRODUCT TYPES
           6.12.2 BUYING CRITERIA
                      FIGURE 28 KEY BUYING CRITERIA FOR ADDITIVES
                      TABLE 7 KEY BUYING CRITERIA FOR ADDITIVES
    6.13 KEY CONFERENCES AND EVENTS, 2022–2023
           TABLE 8 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF CONFERENCES & EVENTS, BY REGION, 2022–2023

7 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE (Page No. - 79)
    7.1 INTRODUCTION
          FIGURE 29 PROBIOTICS SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET BY 2027
          TABLE 9 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
          TABLE 10 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
    7.2 PROBIOTICS
           7.2.1 PROBIOTIC MICROORGANISMS OFFER HEALTH BENEFITS
                    TABLE 11 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 12 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
    7.3 PREBIOTICS
           7.3.1 PREBIOTICS INDUCE GROWTH OF BENEFICIAL GUT BACTERIA
                    7.3.1.1 Oligosaccharides
                    7.3.1.2 Inulin
                    7.3.1.3 Other additives
                                TABLE 13 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                                TABLE 14 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
    7.4 PHYTOGENICS
           7.4.1 PHYTOGENIC FEED ADDITIVES OFFER MORE THAN FLAVORING PROPERTIES
                    7.4.1.1 Essential oils
                    7.4.1.2 Flavonoids
                    7.4.1.3 Saponins
                    7.4.1.4 Oleoresins
                    7.4.1.5 Other additives
                                TABLE 15 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                                TABLE 16 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
    7.5 IMMUNOSTIMULANTS
           7.5.1 IMMUNOSTIMULANTS IMPROVE IMMUNITY AND REDUCE STRESS AND DISEASES IN AQUACULTURE
                    TABLE 17 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 18 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)

8 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK (Page No. - 90)
    8.1 INTRODUCTION
          FIGURE 30 POULTRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
          TABLE 19 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
          TABLE 20 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
    8.2 POULTRY
           8.2.1 FEED ADDITIVES ENHANCE POULTRY PERFORMANCE
                    TABLE 21 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION)
                    TABLE 22 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 23 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
                    8.2.1.1 Broilers
                    8.2.1.2 Layers
                    8.2.1.3 Turkey
                    8.2.1.4 Other poultry species
    8.3 SWINE
           8.3.1 RISE IN PORK TRADE AND CONCERNS OVER MEAT SAFETY
                    TABLE 24 PROBIOTIC MICROORGANISMS USED IN SWINE FEED
                    TABLE 25 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 26 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
    8.4 RUMINANTS
           8.4.1 FEED ADDITIVES BOOST PRODUCTION EFFICIENCY IN RUMINANTS
                    TABLE 27 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION)
                    TABLE 28 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 29 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
                    8.4.1.1 Dairy cattle
                    8.4.1.2 Beef cattle
                    8.4.1.3 Calves
                    8.4.1.4 Other ruminant species
    8.5 AQUACULTURE
           8.5.1 FEED ADDITIVES IMPROVE FEED QUALITY AND ENHANCE AQUACULTURE PERFORMANCE
                    TABLE 30 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 31 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
    8.6 OTHER LIVESTOCK
           8.6.1 PHYTOGENIC-BASED ANIMAL INTESTINAL PRODUCTS IMPROVE DIGESTIBILITY IN PETS
                    TABLE 32 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 33 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)

9 ANIMAL INTESTINAL HEALTH MARKET, BY FORM (Page No. - 103)
    9.1 INTRODUCTION
           FIGURE 31 DRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
           TABLE 34 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
           TABLE 35 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
    9.2 DRY
           9.2.1 EASE OF STORAGE AND TRANSPORTATION
                    TABLE 36 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 37 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
    9.3 LIQUID
           9.3.1 LIQUID SUPPLEMENTS PROVIDE UNIFORM TEXTURE TO FINAL PRODUCTS
                    TABLE 38 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 39 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)

10 ANIMAL INTESTINAL HEALTH MARKET, BY FUNCTION (Page No. - 109)
     10.1 METABOLISM
             10.1.1 ADDITIVES IMPROVE SURVIVAL AND IMPLANTATION OF LIVE MICROBIAL DIETARY SUPPLEMENTS IN GI TRACT
     10.2 WEIGHT GAIN
             10.2.1 FEED ADDITIVES IMPROVE PRODUCTION AND PERFORMANCE OF RUMINANTS
     10.3 NUTRIENT DIGESTION
             10.3.1 FEED ADDITIVES IMPROVE DIGESTIBILITY OF NUTRIENTS
     10.4 DISEASE PREVENTION
             10.4.1 USE OF FEED ADDITIVES PREVENTS DISEASES IN ANIMALS AND IMPROVES HEALTH
     10.5 BONE AND JOINT HEALTH
             10.5.1 PREBIOTICS BETTER CALCIUM METABOLISM AND BONE HEALTH

11 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE (Page No. - 112)
     11.1 INTRODUCTION
             FIGURE 32 MICROBIAL SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
             TABLE 40 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 41 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
     11.2 MICROBIAL
             11.2.1 PROBIOTICS PREPARED USING BACILLUS SUBTILIS AND STREPTOCOCCI IMPROVE EFFICIENCY IN POULTRY AND SWINE
                        TABLE 42 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                        TABLE 43 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
     11.3 PLANT-BASED
             11.3.1 PLANT-BASED SUBSTANCES IMPROVE NUTRIENT DIGESTIBILITY IN ANIMALS
                        TABLE 44 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                        TABLE 45 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)

12 ANIMAL INTESTINAL HEALTH MARKET, BY REGION (Page No. - 118)
     12.1 INTRODUCTION
             FIGURE 33 INDIA EXPECTED TO WITNESS HIGH GROWTH IN ANIMAL INTESTINAL HEALTH MARKET BETWEEN 2022 AND 2027
             TABLE 46 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
             TABLE 47 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027(KT)
     12.2 NORTH AMERICA
             FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT
             TABLE 48 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 49 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 50 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
             TABLE 51 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 52 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 53 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 54 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
             TABLE 55 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
             TABLE 56 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
             12.2.1 US
                        12.2.1.1 Rise in consumption of poultry products
                                      TABLE 57 US: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.2.2 CANADA
                        12.2.2.1 Food safety concerns and government regulations
                                      TABLE 58 CANADA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.2.3 MEXICO
                        12.2.3.1 Rise in import of high-quality meat products
                                      TABLE 59 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
     12.3 EUROPE
             TABLE 60 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 61 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 62 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
             TABLE 63 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 64 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 65 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 66 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
             TABLE 67 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
             TABLE 68 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
             12.3.1 SPAIN
                        12.3.1.1 Increased demand for meat and dairy products
                                      TABLE 69 SPAIN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.2 GERMANY
                        12.3.2.1 Focus on offering high-quality meat products
                                      TABLE 70 GERMANY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.3 FRANCE
                        12.3.3.1 Rising instances of disease outbreaks
                                      TABLE 71 FRANCE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.4 ITALY
                        12.3.4.1 Need for alternative growth promoters encourage use of probiotics
                                      TABLE 72 ITALY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.5 UK
                        12.3.5.1 Intensive farming results in high use of premium quality nutrients in animal intestinal health products
                                      TABLE 73 UK: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.6 REST OF EUROPE
                        12.3.6.1 Need for alternatives to antibiotic growth promoters encourage demand for phytogenics
                                      TABLE 74 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
     12.4 ASIA PACIFIC
             FIGURE 35 ASIA PACIFIC: REGIONAL SNAPSHOT
             TABLE 75 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 76 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 77 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
             TABLE 78 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 79 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 80 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
             TABLE 81 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
             TABLE 82 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 83 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
             12.4.1 CHINA
                        12.4.1.1 High consumption of meat
                                      TABLE 84 CHINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.2 JAPAN
                        12.4.2.1 Preference for high-quality feed products
                                      TABLE 85 JAPAN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.3 INDIA
                        12.4.3.1 Growing demand for high-quality poultry products
                                      TABLE 86 INDIA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.4 SOUTH KOREA
                        12.4.4.1 Increase in consumption of meat products
                                      TABLE 87 SOUTH KOREA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.5 AUSTRALIA & NEW ZEALAND
                        12.4.5.1 High consumption of meat products
                                      TABLE 88 AUSTRALIA & NEW ZEALAND: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.6 REST OF ASIA PACIFIC
                        12.4.6.1 Commercialization of livestock products
                                      TABLE 89 REST OF ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
     12.5 SOUTH AMERICA
             TABLE 90 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 91 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 92 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
             TABLE 93 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 94 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 95 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 96 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
             TABLE 97 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
             TABLE 98 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
             12.5.1 BRAZIL
                        12.5.1.1 High demand for meat products due to high purchasing power of people
                                      TABLE 99 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.5.2 ARGENTINA
                        12.5.2.1 Growth in animal husbandry sector
                                      TABLE 100 ARGENTINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.5.3 REST OF SOUTH AMERICA
                        12.5.3.1 Increased awareness among farmers about importance of feed supplements
                                      TABLE 101 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
     12.6 REST OF THE WORLD
             TABLE 102 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 103 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 104 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
             TABLE 105 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 106 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 107 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 108 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
             TABLE 109 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
             TABLE 110 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
             12.6.1 MIDDLE EAST
                        12.6.1.1 High demand for animal-based protein products
                                      TABLE 111 MIDDLE EAST: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.6.2 AFRICA
                        12.6.2.1 Improvement in livestock health
                                      TABLE 112 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)

13 COMPETITIVE LANDSCAPE (Page No. - 153)
     13.1 OVERVIEW
     13.2 MARKET EVALUATION FRAMEWORK
             FIGURE 36 MARKET EVALUATION FRAMEWORK, 2019–2022
     13.3 MARKET SHARE ANALYSIS
             TABLE 113 ANIMAL INTESTINAL HEALTH MARKET SHARE ANALYSIS, 2021
     13.4 REVENUE ANALYSIS FOR KEY COMPANIES, 2019-2021 (USD BILLION)
             FIGURE 37 REVENUE ANALYSIS OF KEY COMPANIES, 2019-2021 (USD BILLION)
     13.5 COMPANY EVALUATION QUADRANT
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE PLAYERS
             13.5.4 PARTICIPANTS
                        FIGURE 38 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2021
     13.6 STARTUP EVALUATION QUADRANT
             13.6.1 PROGRESSIVE COMPANIES
             13.6.2 STARTING BLOCKS
             13.6.3 RESPONSIVE COMPANIES
             13.6.4 DYNAMIC COMPANIES
                        FIGURE 39 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS, 2021
     13.7 PRODUCT FOOTPRINT (KEY PLAYERS)
             TABLE 114 COMPANY FOOTPRINT, BY LIVESTOCK
             TABLE 115 COMPANY FOOTPRINT, BY ADDITIVE
             TABLE 116 COMPANY FOOTPRINT, BY REGION
             TABLE 117 OVERALL COMPANY FOOTPRINT
             13.7.1 COMPETITIVE BENCHMARKING OF KEY PLAYERS
                        TABLE 118 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF KEY PLAYERS
             13.7.2 COMPETITIVE BENCHMARKING OF SMES/OTHER PLAYERS
                        TABLE 119 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF SMES/OTHER PLAYERS
     13.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
             13.8.1 NEW PRODUCT LAUNCHES
                        TABLE 120 ANIMAL INTESTINAL HEALTH MARKET: NEW PRODUCT LAUNCHES, 2019-2021
             13.8.2 OTHER DEVELOPMENTS
                        TABLE 121 ANIMAL INTESTINAL HEALTH MARKET: OTHER DEVELOPMENTS, 2019-2020
             13.8.3 DEALS
                        TABLE 122 ANIMAL INTESTINAL HEALTH MARKET: DEALS, 2020-2021

14 COMPANY PROFILES (Page No. - 168)
(Business overview, Products offered, Recent Developments, MNM view)*
     14.1 KEY PLAYERS
             14.1.1 ADM
                        TABLE 123 ADM: BUSINESS OVERVIEW
                        FIGURE 40 ADM: COMPANY SNAPSHOT
                        TABLE 124 ADM: PRODUCTS OFFERED
                        TABLE 125 ADM: OTHERS, 2021
                        TABLE 126 ADM: PRODUCT LAUNCHES, 2020
             14.1.2 KONINKLIJKE DSM N.V.
                        TABLE 127 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW
                        FIGURE 41 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
                        TABLE 128 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED
                        TABLE 129 KONINKLIJKE DSM N.V.: DEALS, 2020
             14.1.3 DUPONT NUTRITION & BIOSCIENCES (DANISCO ANIMAL NUTRITION)
                        TABLE 130 DUPONT NUTRITION & BIOSCIENCES: BUSINESS OVERVIEW
                        FIGURE 42 DUPONT NUTRITION & BIOSCIENCES: COMPANY SNAPSHOT
                        TABLE 131 DUPONT NUTRITION & BIOSCIENCES: PRODUCTS OFFERED
                        TABLE 132 DUPONT NUTRITION & BIOSCIENCES: DEALS, 2019-2021
                        TABLE 133 DUPONT NUTRITION & BIOSCIENCES: PRODUCT LAUNCHES, 2019
                        TABLE 134 DUPONT NUTRITION & BIOSCIENCES: OTHERS, 2020
             14.1.4 CARGILL INCORPORATED
                        TABLE 135 CARGILL INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 43 CARGILL INC.: COMPANY SNAPSHOT
                        TABLE 136 CARGILL INCORPORATED: PRODUCTS OFFERED
                        TABLE 137 CARGILL INCORPORATED: DEALS, 2020
                        TABLE 138 CARGILL INCORPORATED: OTHERS, 2022
             14.1.5 NOVOZYMES
                        TABLE 139 NOVOZYMES: BUSINESS OVERVIEW
                        FIGURE 44 NOVOZYMES: COMPANY SNAPSHOT
                        TABLE 140 NOVOZYMES: PRODUCTS OFFERED
                        TABLE 141 NOVOZYMES: DEALS, 2020
             14.1.6 KEMIN INDUSTRIES INC.
                        TABLE 142 KEMIN INDUSTRIES INC.: BUSINESS OVERVIEW
                        TABLE 143 KEMIN INDUSTRIES INC.: PRODUCTS OFFERED
                        TABLE 144 KEMIN INDUSTRIES: PRODUCT LAUNCHES, 2020
             14.1.7 NUTRECO
                        TABLE 145 NUTRECO: BUSINESS OVERVIEW
                        FIGURE 45 NUTRECO: COMPANY SNAPSHOT
                        TABLE 146 NUTRECO: PRODUCTS OFFERED
                        TABLE 147 NUTRECO: DEALS 2019-2020
             14.1.8 CHR. HANSEN HOLDING A/S
                        TABLE 148 CHR. HANSEN HOLDING A/S: BUSINESS OVERVIEW
                        FIGURE 46 CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT
                        TABLE 149 CHR. HANSEN HOLDING A/S: PRODUCTS OFFERED
                        TABLE 150 CHR. HANSEN HOLDING A/S: PRODUCT LAUNCHES, 2019-2021
                        TABLE 151 CHR. HANSEN HOLDING A/S: DEALS, 2020
             14.1.9 BLUESTAR ADISSEO CO. LTD.
                        TABLE 152 BLUESTAR ADISSEO: BUSINESS OVERVIEW
                        FIGURE 47 BLUESTAR ADISSEO CO. LTD.: COMPANY SNAPSHOT
                        TABLE 153 BLUESTAR ADISSEO CO. LTD.: PRODUCTS OFFERED
                        TABLE 154 BLUESTAR ADISSEO CO. LTD.: DEALS, 2020
             14.1.10 ALLTECH
                        TABLE 155 ALLTECH: BUSINESS OVERVIEW
                        TABLE 156 ALLTECH: PRODUCTS OFFERED
             14.1.11 EVONIK INDUSTRIES
                        TABLE 157 EVONIK INDUSTRIES: BUSINESS OVERVIEW
                        FIGURE 48 EVONIK INDUSTRIES: COMPANY SNAPSHOT
                        TABLE 158 EVONIK INDUSTRIES: PRODUCTS OFFERED
                        TABLE 159 EVONIK INDUSTRIES: PRODUCT LAUNCHES, 2020
             14.1.12 LALLEMAND INC.
                        TABLE 160 LALLEMAND INC.: BUSINESS OVERVIEW
                        TABLE 161 LALLEMAND INC.: PRODUCTS OFFERED
                        TABLE 162 LALLEMAND INC.: OTHER DEVELOPMENTS, 2019-2020
             14.1.13 BIORIGIN
                        TABLE 163 BIORIGIN: BUSINESS OVERVIEW
                        TABLE 164 BIORIGIN: PRODUCTS OFFERED
                        TABLE 165 BIORIGIN: DEALS, 2019
             14.1.14 LAND O’LAKES
                        TABLE 166 LAND O’LAKES: BUSINESS OVERVIEW
                        FIGURE 49 LAND O’LAKES: COMPANY SNAPSHOT
                        TABLE 167 LAND O’LAKES: PRODUCTS OFFERED
                        TABLE 168 LAND O’LAKES: OTHERS, 2019
                        TABLE 169 LAND O’LAKES: DEALS, 2019
             14.1.15 LESAFFRE
                        TABLE 170 LESAFFRE: BUSINESS OVERVIEW
                        TABLE 171 LESAFFRE: PRODUCTS OFFERED
                        TABLE 172 LESAFFRE: OTHER DEVELOPMENTS, 2019-2020
                        TABLE 173 LESAFFRE: PRODUCT LAUNCHES, 2019
             14.1.16 CALPIS CO LTD
                         TABLE 174 CALPIS CO LTD.: BUSINESS OVERVIEW
             14.1.17 AB VISTA
             14.1.18 PURE CULTURES
             14.1.19 DR. ECKEL ANIMAL NUTRITION GMBH & CO. KG
             14.1.20 UNIQUE BIOTECH

*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

15 ADJACENT AND RELATED MARKETS (Page No. - 218)
     15.1 INTRODUCTION
            TABLE 175 ADJACENT MARKETS TO ANIMAL INTESTINAL HEALTH
     15.2 LIMITATIONS
     15.3 PHYTOGENIC FEED ADDITIVES MARKET
             15.3.1 MARKET DEFINITION
             15.3.2 MARKET OVERVIEW
                        TABLE 176 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2016–2019 (USD MILLION)
                        TABLE 177 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2020–2025 (USD MILLION)
     15.4 PROBIOTICS IN ANIMAL FEED MARKET
             15.4.1 MARKET DEFINITION
                        TABLE 178 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2017–2020 (USD MILLION)
                        TABLE 179 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2021–2026 (USD MILLION)

16 APPENDIX (Page No. - 222)
     16.1 DISCUSSION GUIDE
     16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     16.3 AVAILABLE CUSTOMIZATION
     16.4 RELATED REPORTS
     16.5 AUTHOR DETAILS